Dr. Barry Kappel is the founder, president, chief executive officer and director of Sapience Therapeutics. Prior to founding Sapience, Barry was a senior executive of ContraFect Corporation, a company which he played an integral part in founding in 2009. Prior to ContraFect, he was a Senior Consultant at Easton Associates, LLC, a boutique life science consulting firm located in Manhattan.
Dr. Kappel holds B.A. in Chemistry from Emory University, a Ph.D. in Biomedical Sciences from the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan-Kettering Cancer Center, and an MBA from the S.C. Johnson Graduate School of Management at Cornell University. Dr. Kappel was also chosen as a Howard Hughes Pre-Doctoral Fellow.